首页> 外文期刊>Free radical research >Neopterin and 7,8-dihydroneopterin interfere with low density lipoprotein oxidation mediated by peroxynitrite and/or copper.
【24h】

Neopterin and 7,8-dihydroneopterin interfere with low density lipoprotein oxidation mediated by peroxynitrite and/or copper.

机译:新蝶呤和7,8-二氢蝶呤可干扰过氧亚硝酸盐和/或铜介导的低密度脂蛋白氧化。

获取原文
获取原文并翻译 | 示例
       

摘要

Low density lipoprotein (LDL) oxidation within the artery wall likely represents a key event in the formation of atherosclerotic lesions. Oxidatively modified LDL particles exert chemotactic properties on macrophages, and the uncontrolled uptake of modified LDL by macrophages leads to the formation of lipid-loaded foam cells, a hallmark of early stage atherosclerosis. Human macrophages stimulated by interferon-gamma generate reactive oxygen species (ROS), neopterin, and 7,8-dihydroneopterin. Higher concentrations of neopterin were found in atherosclerosis, and earlier studies have provided evidence that these neopterin derivatives are able to interfere with reactive species. We therefore investigated whether they also modulate LDL oxidation mediated by Cu(II) and/or peroxynitrite (ONOO-). By means of UV-absorption recording the formation of conjugated dienes in the course of lipid oxidation as well as by measuring the relative electrophoretic mobility of oxidized LDL, we found that neopterin is capable of enhancing ONOO- - as well as Cu(II)-mediated LDL oxidation, whereas 7,8-dihydroneopterin mainly protects LDL from oxidation. However, in case of Cu(II)-mediated LDL oxidation, an initial prooxidative effect of 7,8-dihydroneopterin could be observed. We hypothesize that 7,8-dihydroneopterin may chemically reduce Cu(II) to Cu(I) thereby increasing its oxidative capacity. After total reduction of Cu(II), excess 7,8-dihydroneopterin may block the oxidative potential of Cu(I) and thus decrease the oxidation of LDL. These findings confirm the general behavior of pteridines in redox processes and suggest an in vivo contribution to the process of LDL oxidation.
机译:动脉壁内的低密度脂蛋白(LDL)氧化可能代表了动脉粥样硬化病变形成中的关键事件。氧化修饰的LDL颗粒在巨噬细胞上发挥趋化特性,巨噬细胞对修饰的LDL的不加控制的吸收导致形成脂质负载的泡沫细胞,这是早期动脉粥样硬化的标志。干扰素-γ刺激的人类巨噬细胞产生活性氧(ROS),新蝶呤和7,8-二氢蝶呤。在动脉粥样硬化中发现了更高浓度的新蝶呤,并且较早的研究提供了证据,这些新蝶呤衍生物能够干扰反应性物种。因此,我们研究了它们是否也调节由Cu(II)和/或过氧亚硝酸盐(ONOO-)介导的LDL氧化。通过紫外吸收记录脂质氧化过程中共轭二烯的形成以及通过测量氧化的LDL的相对电泳迁移率,我们发现新蝶呤能够增强ONOO-和Cu(II)-介导的LDL氧化,而7,8-二氢蝶呤则主要保护LDL免受氧化。但是,在Cu(II)介导的LDL氧化的情况下,可以观察到7,8-二氢蝶呤的初始促氧化作用。我们假设7,8-dihydroneopterin可以化学还原Cu(II)到Cu(I),从而增加其氧化能力。在完全还原Cu(II)之后,过量的7,8-二氢蝶呤可能会阻断Cu(I)的氧化电位,从而降低LDL的氧化。这些发现证实了蝶啶在氧化还原过程中的一般行为,并暗示了体内对LDL氧化过程的贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号